Dermal Toxicity Evaluation of Rifampicin Loaded Lipidic Nanoparticle Nanogel for Topical Delivery
International Journal of Drug Delivery Technology · 01.07.2026 · 16 (60s)
DOI: 10.25258/ijddt.16.60s.196 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 01.07.2026. Verfasst von Neeraj Kumar und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Objective
The present study aimed to evaluate dermal safety of rifampicin loaded solid lipid nanoparticle (SLN) nanogel for topical delivery through skin irritation, dermal toxicity, hematological and biomedical analysis and histopathological examination of skin.
Methods
Rifampicin-loaded SLNs were incorporated into a Carbopol 934P-based gel and optimized using a three-factor, three-level Box Behnken experimental design (DoE). The independent variables included gelling agent concentration, triethanolamine concentration, and stirring speed. The optimization formulation was evaluated for skin irritation study, dermal toxicity parameters such as acute and repeated dose dermal toxicity study, evaluations of hematological and biomedical parameter of blood and histopathological assessment of treated skin.
Results
The optimized SLN nanogel exhibited no visible signs of erythema and edema, redness, inflammation or skin damage. No mortality, abnormal behaviour or significant changes in body weight were observed during repeated dose toxicity studies. Hematological and biomedical parameter remained within normal limits indicating absence of systemic toxicity. histopathological examination showed normal skin architecture without necrosis, inflammation or tissue degradation.
Conclusion
These finding confirmed that rifampicin loaded SLN nanogel was safe non-irritant and suitable for topical application. Therefore, the developed formulation may be considered a promising carrier system for localized dermal delivery of rifampicin. warranting further advanced in-vivo and clinical investigations.
Zitieren
APA
Kumar, N., & Bala, R. (2026). Dermal Toxicity Evaluation of Rifampicin Loaded Lipidic Nanoparticle Nanogel for Topical Delivery. International Journal of Drug Delivery Technology, 16(60s). https://doi.org/10.25258/ijddt.16.60s.196
Vancouver
Kumar N, Bala R. Dermal Toxicity Evaluation of Rifampicin Loaded Lipidic Nanoparticle Nanogel for Topical Delivery. International Journal of Drug Delivery Technology. 2026;16(60s). doi:10.25258/ijddt.16.60s.196
BibTeX
@article{Kumar2026,
author = {Kumar, Neeraj and Bala, Rajni},
title = {Dermal Toxicity Evaluation of Rifampicin Loaded Lipidic Nanoparticle Nanogel for Topical Delivery},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {60s},
doi = {10.25258/ijddt.16.60s.196}
}
EUVIMED